Natural history and surgical treatment of chordoma

a retrospective cohort study

Authors

  • Samuel Aguiar Júnior Hospital A. C. Camargo
  • Wesley Pereira Andrade Hospital A. C. Camargo
  • Glauco Baiocchi Hospital A. C. Camargo
  • Gustavo Cardoso Guimarães Hospital A. C. Camargo
  • Isabela Werneck Cunha Hospital A. C. Camargo
  • Daniel Alvarez Estrada Hospital A. C. Camargo
  • Sergio Hideki Suzuki Hospital A. C. Camargo
  • Luiz Paulo Kowalski Hospital A. C. Camargo
  • Ademar Lopes Hospital A. C. Camargo

Keywords:

Chordoma, Surgical procedures, operative, Recurrence, Survival, Risk factors, Mortality

Abstract

CONTEXT AND OBJECTIVE: Chordoma is a rare tumor with a high risk of locoregional recurrences. The aim of this study was analyze the long-term results from treating this pathological condition. DESIGN AND SETTING: Cohort study in a single hospital in São Paulo, Brazil. METHODS: This was a retrospective cohort study on 42 patients with chordoma who were treated at Hospital A. C. Camargo between 1980 and 2006. The hospital records were reviewed and a descriptive analysis was performed on the clinical-pathological variables. Survival curves were estimated using the Kaplan-Meier method and these were compared using the log-rank test. RESULTS: Nineteen patients were men and 23 were women. Twenty-five tumors (59.5%) were located in the sacrum, eleven (26.2%) in the skull base and six (14.3%) in the mobile spine. Surgery was performed on 28 patients (66.7%). The resection was considered to have negative margins in 14 cases and positive margins in 14 cases. The five-year overall survival (OS) was 45.4%. For surgical patients, the five-year OS was 64.3% (82.2% for negative margins and 51.9% for positive margins). In the inoperable group, OS was 37.7% at 24 months and 0% at five years. CONCLUSION: Complete resection is related to local control and definitively has a positive impact on long-term survival.

Downloads

Download data is not yet available.

Author Biographies

Samuel Aguiar Júnior, Hospital A. C. Camargo

MD, PhD. Surgical Oncologist, Department of Pelvic Surgery, Hospital A. C. Camargo, São Paulo, Brazil.

Wesley Pereira Andrade, Hospital A. C. Camargo

MD, MSc. Surgical Oncologist, Department of Pelvic Surgery, Hospital A. C. Camargo, São Paulo, Brazil.

Glauco Baiocchi, Hospital A. C. Camargo

MD, PhD. Surgical Oncologist, Department of Pelvic Surgery, Hospital A. C. Camargo, São Paulo, Brazil.

Gustavo Cardoso Guimarães, Hospital A. C. Camargo

MD, PhD. Surgical Oncologist, Department of Pelvic Surgery, Hospital A. C. Camargo, São Paulo, Brazil.

Isabela Werneck Cunha, Hospital A. C. Camargo

MD, PhD. Pathologist, Department of Pathology, Hospital A. C. Camargo, São Paulo, Brazil.

Daniel Alvarez Estrada, Hospital A. C. Camargo

MD. Neurosurgeon, Department of Neurosurgery, Hospital A. C. Camargo, São Paulo, Brazil.

Sergio Hideki Suzuki, Hospital A. C. Camargo

MD. Neurosurgeon, Department of Neurosurgery, Hospital A. C. Camargo, São Paulo, Brazil.

Luiz Paulo Kowalski, Hospital A. C. Camargo

MD, PhD. Head and Neck Surgeon, Department of Head and Neck Surgery, São Paulo, Brazil.

Ademar Lopes, Hospital A. C. Camargo

MD, PhD. Head of Department of Pelvic Surgery, Hospital A. C. Camargo, São Paulo, Brazil.

References

Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003;10(3):291-6.

Bergh P, Kindblom LG, Gunterberg B, et al. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122-34.

Eriksson B, Gunterberg B, Kindblom LG. Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand. 1981;52(1):49-58.

Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus. 2003;15(2):E9.

Lopes A, Rossi BM, Silveira CR, Alves AC. Chordoma: retrospective analysis of 24 cases. Sao Paulo Med J. 1996;114(6):1312-6.

Azzarelli A, Quagliuolo V, Cerasoli S, et al. Chordoma: natural history and treatment results in 33 cases. J Surg Oncol. 1988;37(3):185-91.

York JE, Kaczaraj A, Abi-Said D, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44(1):74-9; discussion 79-80.

Crapanzano JP, Ali SZ, Ginsberg MS, Zakowski MF. Chordoma: a cytologic study with histologic and radiologic correlation. Cancer. 2001;93(1):40-51.

Xu WP, Song XW, Yue SY, Cai YB, Wu J. Primary sacral tumors and their surgical treatment. A report of 87 cases. Chin Med J (Engl). 1990;103(11):879-84.

Chandawarkar RY. Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg. 1996;20(6):717-9.

Kaiser TE, Pritchard DJ, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984;53(11):2574-8.

Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am. 2005;87(10):2211-6.

Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila PA 1976). 2006;31(4):493-503.

Osaka S, Kodoh O, Sugita H, et al. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol. 2006;132(4):213-8.

Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery. 2006;59(2):230-7; discussion 230-7.

Ferraresi V, Nuzzo C, Zoccali C, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010;10:22.

Magrini SM, Papi MG, Marletta F, et al. Chordoma-natural history, treatment and prognosis. The Florence Radiotherapy Department experience (1956-1990) and a critical review of the literature. Acta Oncol. 1992;31(8):847-51.

Mindell ER. Chordoma. J Bone Joint Surg Am. 1981;63(3):501-5.

Sciubba DM, Cheng JJ, Petteys RJ, et al. Chordoma of the sacrum and vertebral bodies. J Am Acad Orthop Surg. 2009;17(11):708-17.

Bjornsson J, Wold LE, Ebersold MJ, Laws ER. Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer. 1993;71(3):735-40.

Imai R, Kamada T, Sugahara S, Tsuji H, Tsujii H. Carbon ion radiotherapy for sacral chordoma. Br J Radiol. 2011;84 Spec No 1:S48-54.

Combs SE, Kalbe A, Nikoghosyan A, et al. Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol. 2011;98(1):63-7.

Downloads

Published

2014-10-10

How to Cite

1.
Aguiar Júnior S, Andrade WP, Baiocchi G, Guimarães GC, Cunha IW, Estrada DA, Suzuki SH, Kowalski LP, Lopes A. Natural history and surgical treatment of chordoma: a retrospective cohort study. Sao Paulo Med J [Internet]. 2014 Oct. 10 [cited 2025 Oct. 15];132(5):297-302. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/1236

Issue

Section

Original Article